• Click and Discover Platform set to buck trends in Drug Development
    Professor John Overington

News & Views

Click and Discover Platform set to buck trends in Drug Development

Aug 31 2021

Bioinformatics has seen the emergence of the first no-code, pay as you go drug discovery platform that simplifies access to AI models for SME’s at the click of a button. Developed by Chief.AI in partnership with the Medicines Discovery Catapult (MDC), the cloud-based system provides access to information, skills and resources along with production infrastructure and analytics for models without the need for substantial and expensive internal IT capabilities.
Supported by an Innovate UK grant, the project is based on the development of models by MDC, with Chief.AI providing the orchestration engine.
The ability to utilise AI in this way could provide huge advantages in terms of costs and timing as well as making efficient use of resources. For example, it could be used to analyse and predict the behaviour of molecules in the human body much earlier than traditional methods, which financially could save billions in research and development.
“As an orchestrator of AI, we are delighted to be able to make access to AI easier and more effective for healthcare providers around the world. Artificial intelligence will prove to be a great force multiplier for data intensive applications such as drug discovery and diagnostics and with the help of the Medicines Discovery Catapult, Chief.AI is strategically poised to enable businesses around the world to connect to AI and reap these efficiencies seamlessly,” said Chief.AI founder Waqar Ali.

Professor John P. Overington, Chief Informatics Officer, Medicines Discovery Catapult, added: “This is a very exciting time for drug discovery. The development and utilisation of AI has been something that the industry has needed to propel that next step forward, and with Chief.AI it is now possible. AI is going to be something that will permeate across all aspects of society and business in the years to come and it is wonderful that we are able to offer this platform to UK SMEs, providing them with information and expertise which otherwise would have been inaccessible.”

More information online


Digital Edition

Lab Asia 31.2 April 2024

April 2024

In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...

View all digital editions

Events

Microbiology Society Annual Conference 2024

Apr 08 2024 Edinburgh 2024

analytica 2024

Apr 09 2024 Munich, Germany

ChemBio Finland 2024

Apr 10 2024 Helsinki, Finland

Analytica Anacon India & IndiaLabExpo

Apr 15 2024 Mumbai, India

Analitika Expo 2024

Apr 16 2024 Moscow, Russia

View all events